Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin

References

1. Ahlfors E., Czerkinsky C. 1991; Contact sensitivity in the murine oral mucosa. I. An experimental model of delayed-type hypersensivity reactions at mucosal surfaces. Clinical and Experimental Immunology 86:449–456
   [Google Scholar]
2. Albrecht P., Ennis F. A., Saltzman E. J., Krugman S. 1977; Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. Journal of Pediatrics 91:715–718
   [Google Scholar]
3. Ban E. M., vanGinkel F. W., Simecka J. W., Curiel D. T., Kiyono H., McGhee J. R. 1996; Mucosal immunization with DNA encoding influenza A hemagglutinin (abstract). In Nucleic Acid Vaccines for the Prevention of Infectious Diseases Bethesda: NIH;
   [Google Scholar]
4. Beauverger P., Buckland R., Wild T. F. 1993; Measles virus antigen induce both type-specific and canine distemper virus crossreactive cytotoxic T lymphocytes in mice: localization of a common Ld- restricted nucleoprotein epitope. Journal of General Virology 74:2357–2363
   [Google Scholar]
5. Cardoso A., Blixenkröne-Moller M., Fayolle J., Liu M., Buckland R., Wild T. F. 1996; Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell mediated immunity. Virology 225:293–299
   [Google Scholar]
6. Corr M., Lee D. J., Carson D. A., Tighe H. 1996; Gene vaccination with naked plasmid DNA: mechanism of CTL priming. Journal of Experimental Medicine 184:1555–1560
   [Google Scholar]
7. Eriksson K., Ahlfors E., George-Chandy A., Kaiserlian D., Czerkinsky C. 1996; Antigen presentation in the murine oral epithelium. Immunology 88:147–152
   [Google Scholar]
8. Etchart N., Wild F., Kaiserlian D. 1996; Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus. Journal of General Virology 77:2471–2478
   [Google Scholar]
9. Fynan E. F., Webster R. G., Fuller D. H., Haynes J. R., Santoro J. C., Robinson H. L. 1993; DNA vaccines : prospective immunizations by parenteral, mucosal and gene-gun inoculations. Proceedings of the National Academy of Sciences USA: 9011478–11482
   [Google Scholar]
10. Gerald C., Buckland R., Barker R., Freeman G., Wild T. F. 1986; Measles virus haemagglutinin gene : cloning, complete nucleotide sequence analysis and expression in COS cells. Journal of General Virology 67:2695–2703
    [Google Scholar]
11. Hengge U. R., Chan E. F., Walker P. S., Vogel J. C. 1996; Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nature Genetics 10:161
    [Google Scholar]
12. Holmgren J., Lycke N., Czerkinsky C. 1993; Cholera toxin and cholera toxin B-subunit as oral-mucosal adjuvant in antigen vector systems. Vaccine 11:1179–1184
    [Google Scholar]
13. Holt P. G., Haining S., Nelson D. J., Sedgwick J. D. 1994; Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. Journal of Immunology 153:256–261
    [Google Scholar]
14. Hyde S. C., Gill D. R., Higgins C. F., Trezise A. E. O., MacVinish L. J., Cuthbert A. W., Ratcliff R., Evans M. J., Colledge W. H. 1993; Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 362:250–255
    [Google Scholar]
15. Kozak M. 1986; Bifunctional messenger RNAs in eukaryotes. Cell 47:481–483
    [Google Scholar]
16. Liu L. M., MacPherson G. G. 1993; Antigen acquisition by dendritic cells : intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. Journal of Experimental Medicine 177:1299–1307
    [Google Scholar]
17. Meitin C. A., Bender B. S., Small P. A. Jr 1994; Enteric immunization of mice against influenza with recombinant vaccinia. Proceedings of the National Academy of Sciences USA: 9111187–11191
    [Google Scholar]
18. Montgomery D. I., Shiver J. W., Leander K. R., Perry H. C., Fiedman A., Martinez D., Ulmer J. B., Donnelly J. J., Liu M. A. 1993; Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biology 12:777–783
    [Google Scholar]
19. Pertmer T. M., Eisenbraun M. D., McCabe D., Prayaga S. K., Fuller D. H., Haynes J. R. 1995; Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13:1427–1430
    [Google Scholar]
20. Rouse R. J. D., Nair S. K., Lydy S. L., Bowen J. C., Rouse B. T. 1994; Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins. Journal of Virology 68:5685
    [Google Scholar]
21. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M. D., Silverman G. J., Lotz M., Carson D. A., Raz E. 1996; Immuno- stimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352–354
    [Google Scholar]
22. Schödel F., Aguado M.-T., Lambert P.-H. 1994; Introduction. In Nucleic Acid Vaccines WHO; Geneva, Vaccine: 121491–1492
    [Google Scholar]
23. Ulmer J. B., Donnelly J. J., Parker S. E., Rhodes G. H., Felgner P. L., Dwarki V. J., Gromkowski S. H., Deck R. R., DeWitt C. M., Friedman A., Hawe L. A., Leander K. R., Martinez D., Perry H. C., Shiver J. W., Montgomery D. L., Liu M. A. 1993; Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 2 59:1745–1749
    [Google Scholar]
24. Ulmer J. B., Deck R. R., DeWitt C. M., Donnelly J. J., Liu M. A. 1996a; Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells : antigen presentation by non-muscle cells. Immunology 89:59–67
    [Google Scholar]
25. Ulmer J. B., Shiver J. W., Caulfield M., Liu M. A., Donnelly J. J. 1996b; Mechanisms of immunity and antigen presentation with DNA vaccines (abstract). In Nucleic Acid Vaccines for the Prevention of Infectious Diseases Bethesda: NIH;
    [Google Scholar]
26. Walker R. I. 1994; New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12:387–400
    [Google Scholar]